Education
About Us
Working with TipRanks
Follow Us
XMAG - ETF AI Analysis
Top Page
Defiance Large Cap ex-Mag 7 ETF (XMAG)
Rating:72Outperform
Price Target:―
Positive Factors
Well-Known Large-Cap Holdings
The ETF holds many established blue-chip companies, which can provide stability and recognizable brand strength in the portfolio.
Broad Sector Diversification
Exposure across many sectors, including technology, financials, health care, and consumer stocks, helps reduce the impact if any one industry struggles.
Recent Positive Performance
The fund has shown steady gains over the past month, three months, and year-to-date, indicating improving recent momentum.
Negative Factors
Several Weak Top Holdings
A number of the largest positions, such as major financial and payment companies, have shown weak performance so far this year, which can drag on returns.
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification.
Moderate Expense Ratio
The fund’s fee is not especially low, which means a noticeable portion of returns will go toward covering expenses each year.
XMAG vs. SPDR S&P 500 ETF (SPY)
AUM124.71M
RegionNorth America
Expense Ratio0.35%
Beta0.89
IssuerDefiance
Inception DateOct 21, 2024
Dividend Yield0.5%
Asset ClassEquity
Index TrackedBITA US 500 ex-Magnificent 7 Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume78,908
30 Day Avg. Volume90,373
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
26.78Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering493
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XMAG Summary
XMAG is an ETF that tracks the BITA US 500 ex-Magnificent 7 Index, meaning it invests in large U.S. companies but leaves out the seven biggest tech giants. It holds well-known names like JPMorgan Chase, Berkshire Hathaway, Exxon Mobil, Walmart, and Costco, spread across sectors such as technology, health care, financials, and consumer goods. Someone might invest in XMAG to get broad stock market exposure without being overly tied to the largest tech stocks, which can dominate many funds. A key risk is that it can still rise or fall with the overall stock market, and it may lag funds that include the “Mag 7” if those stocks outperform.
How much will it cost me?The expense ratio for the Defiance Large Cap ex-Mag 7 ETF (XMAG) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to exclude the 'Mag 7' tech giants, requiring more oversight and strategy. It’s designed for investors seeking a unique approach to large-cap stocks.
What would affect this ETF?XMAG's focus on excluding the 'Mag 7' tech giants could benefit from a shift in investor sentiment towards diversification and reduced reliance on mega-cap tech stocks. Positive drivers include potential growth in sectors like financials and healthcare, which are significant holdings, and stability from its broad exposure to U.S. large-cap companies. However, negative factors such as rising interest rates could pressure financial stocks, and economic slowdowns might impact consumer-focused sectors like Consumer Defensive and Consumer Cyclical.
XMAG Top 10 Holdings
XMAG’s story is about spreading big-cap risk beyond the usual tech titans, but its top holdings still pack some drama. On the upside, defensive and consumer names like Costco, Walmart, Johnson & Johnson, and Exxon Mobil are doing the heavy lifting, with steady-to-rising share prices that give the fund a solid backbone. On the other side, payment giants Visa and Mastercard, along with Broadcom and Berkshire Hathaway, have been lagging, acting like a mild headwind. Overall, it’s a U.S.-only portfolio with a tilt toward tech, financials, and health care, yet without the usual “Mag 7” dominance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Broadcom | 3.89% | $4.85M | $1.57T | 52.16% | 76 Outperform | |
| Eli Lilly & Co | 2.22% | $2.77M | $980.50B | 27.98% | 72 Outperform | |
| JPMorgan Chase | 2.11% | $2.63M | $832.71B | 14.65% | 72 Outperform | |
| Berkshire Hathaway B | 1.66% | $2.07M | $1.04T | 3.43% | 66 Neutral | |
| Exxon Mobil | 1.51% | $1.88M | $596.31B | 32.04% | 74 Outperform | |
| Johnson & Johnson | 1.38% | $1.72M | $547.51B | 49.63% | 78 Outperform | |
| Visa | 1.37% | $1.71M | $615.41B | -6.94% | 70 Outperform | |
| Walmart | 1.31% | $1.64M | $949.57B | 19.69% | 78 Outperform | |
| Micron | 1.17% | $1.46M | $466.95B | 361.39% | 79 Outperform | |
| Mastercard | 1.11% | $1.39M | $483.97B | -4.46% | 75 Outperform |
XMAG Technical Analysis
Positive
―
Price Trends
22.62
Positive
22.35
Positive
21.50
Positive
Market Momentum
0.10
Positive
58.19
Neutral
61.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XMAG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 22.97, equal to the 50-day MA of 22.62, and equal to the 200-day MA of 21.50, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 58.19 is Neutral, neither overbought nor oversold. The STOCH value of 61.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XMAG.
XMAG Peer Comparison
Comparison Results
Performance Comparison
XMAG
Defiance Large Cap ex-Mag 7 ETF
23.08
2.45
11.88%
VOTE
Engine No. 1 Transform 500 ETF
―
―
―
NBCR
Neuberger Berman Core Equity ETF
―
―
―
QQQJ
Invesco NASDAQ Next Gen 100 ETF
―
―
―
ONEY
SPDR Russell 1000 Yield Focus ETF
―
―
―
MODL
VictoryShares WestEnd U.S. Sector ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents